Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
Abstract Background Krebs von den Lungen (KL-6) is elevated in serum of interstitial lung disease (ILD) patients based on its leakage from the alveolar space into the blood; KL-6 is significantly higher in patients with acute exacerbation of ILDs (AE-ILD) compared with stable patients. This study ai...
Main Authors: | Zainab H. Saeed, Mohammed H. Magdy, Emad A. Abdelnaem, Madyan M. Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-11-01
|
Series: | The Egyptian Journal of Bronchology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43168-020-00043-w |
Similar Items
-
The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
by: Hua Ma, et al.
Published: (2020-01-01) -
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case–control study
by: Changjiang Xue, et al.
Published: (2017-11-01) -
Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features
by: Jingxian Wang, et al.
Published: (2020-12-01) -
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
by: Tang-Hsiu Huang, et al.
Published: (2021-05-01) -
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
by: Miriana d’Alessandro, et al.
Published: (2021-02-01)